Subcutaneous Alzheimer's Drug May Be on the Horizon

(MedPage Today) -- A subcutaneous version of the newly approved Alzheimer's drug lecanemab (Leqembi) may be on the horizon.
Weekly subcutaneous lecanemab 100 mg/mL injection appeared to be as effective at amyloid plaque removal as biweekly IV...

Source: MedPage Today Neurology - October 27, 2023 Category: Neurology Source Type: news